Table 2.
USKC |
KPNC |
||||||
---|---|---|---|---|---|---|---|
Exposure | Sex/Race | PAR% (95%CI) | P-valueb | PAR%(95%CI) | P-valueb | ||
Hypertension | Female | ||||||
White | 28.5 | (13.4, 43.6) | 0.14 | 27.4 | (20.3, 34.5) | 0.31 | |
Black | 50.1 | (23.5, 76.7) | 39.8 | (17.5, 62.2) | |||
Male | |||||||
White | 26.6 | (14.2, 39.0) | 0.13 | 18.9 | (13.7, 24.1) | 0.72 | |
Black | 44.4 | (24.7, 64.1) | 22.8 | (1.6, 44.1) | |||
CKD | Female | ||||||
White | 0.4 | (−1.5, 2.3) | 0.02 | −0.3 | (−0.8, 0.1) | 0.009 | |
Black | 8.4 | (1.9, 14.9) | 6.9 | (1.5, 12.4) | |||
Male | |||||||
White | 0.6 | (−0.5, 1.6) | 0.002 | 0.0 | (−0.6, 0.5) | 0.0003 | |
Black | 9.4 | (4.0, 14.8) | 10.1 | (4.6, 15.5) | |||
CKD or hypertension | Female | ||||||
White | 29.7 | (15.0, 44.4) | 0.15 | 27.2 | (20.0, 34.4) | 0.17 | |
Black | 51.2 | (25.6, 76.8) | 43.0 | (22.2, 63.8) | |||
Male | |||||||
White | 27.0 | (14.7, 39.3) | 0.04 | 18.9 | (13.7, 24.1) | 0.28 | |
Black | 49.2 | (32.0, 66.3) | 29.4 | (10.5, 48.3) |
Abbreviations: USKC, US Kidney Cancer Study; KPNC, Kaiser Permanente Northern California; PAR, population attributable risk; CI, confidence interval; CKD, chronic kidney disease.
USKC PAR% were calculated from unconditional sample weighted logistic regression models, adjusted for hypertension, CKD, body mass index, smoking status, education, age, study center and family history of cancer. KPNC PAR% were calculated using conditional logistic regression models, conditioned on the matched sets and adjusted for hypertension, CKD, smoking status, and diabetes.
P-value estimated from two sample t-test of difference by race.